Beutel, Goodman & Co’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$100K Hold
1,100
﹤0.01% 131
2026
Q1
$93K Sell
1,100
-300
-21% -$26.7K ﹤0.01% 131
2025
Q4
$110K Hold
1,400
﹤0.01% 129
2025
Q3
$111K Hold
1,400
﹤0.01% 127
2025
Q2
$127K Sell
1,400
-900
-39% -$82.2K ﹤0.01% 124
2025
Q1
$215K Buy
+2,300
New +$206K ﹤0.01% 127
2018
Q2
Sell
-35,159
Closed -$1.95M 64
2018
Q1
$1.95M Sell
35,159
-9,855
-22% -$709K 0.01% 57
2017
Q4
$2.71M Buy
+45,014
New +$3.29M 0.02% 61

Other funds holding CL

Beutel, Goodman & Co's CL Position: Q2 2026 in Review

Beutel, Goodman & Co held its Colgate-Palmolive (CL) position steady in Q2 2026 at 1,100 shares worth $100K. The position accounts for ﹤0.01% of the portfolio, ranked #131.

Beutel, Goodman & Co first reported a position in CL in Q4 2017 and has held it in 8 quarters since. The position peaked at $2.71M in Q4 2017. 2,015 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Beutel, Goodman & Co held 1,100 shares of Colgate-Palmolive worth $100K as of Q2 2026.
  • Beutel, Goodman & Co left its Colgate-Palmolive share count unchanged in Q2 2026.
  • Colgate-Palmolive made up ﹤0.01% of Beutel, Goodman & Co's portfolio in Q2 2026, its #131 holding.
  • Beutel, Goodman & Co first reported a position in Colgate-Palmolive in Q4 2017 and has held it in 8 quarters since.
  • Beutel, Goodman & Co's Colgate-Palmolive position peaked at $2.71M in Q4 2017.
  • 2,015 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Beutel, Goodman & Co's 13F filing for Q2 2026, filed 12 Aug 2026.